Vitamin D3 50,000IU Compounded Product Recalled for Sterility Assurance Failure
Tailor Made Compounding has recalled Vitamin D3 50,000IU/mL vials nationwide due to lack of sterility assurance during manufacturing. No illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a compounded pharmaceutical due to sterility assurance failure. No illnesses or injuries have been reported. While potential contamination poses health risk, the hazard remains theoretical without confirmed harm.
Plain-English summary
Tailor Made Compounding is recalling Vitamin D3 50,000IU/mL compounded product due to lack of assurance of sterility. The affected batch (02252201A1, expiration 4/15/2022) consists of 15 vials distributed nationwide in the United States and Puerto Rico.
The recall was issued because insufficient controls were in place to ensure the sterility of the product during manufacturing. No illnesses or injuries associated with this product have been reported to date.
Patients who have this product should not use any remaining vials. Contact your healthcare provider for guidance on proper disposal and to discuss continued vitamin D supplementation.
The recalled product
- Product
- Vitamin D3 50,000IU/mL, 10mL-vial, Room Temperature, Tailor Made Compounding
- Manufacturer
- TMC Acquisition LLC dba Tailor Made Compounding
- Category
- Drug — Compounded pharmaceutical
- Hazard
- sterility-failure
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch#: 02252201A1
- Exp 4/15/2022.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01